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Parkinson disease affects more than 1% of the population over 60 y old. The dominant models for Parkinson disease are
based on the use of chemical toxins to kill dopamine neurons, but do not address the risk factors that normally increase
with age. Forkhead transcription factors are critical regulators of survival and longevity. The forkhead transcription
factor, foxa2, is specifically expressed in adult dopamine neurons and their precursors in the medial floor plate. Gain-
and loss-of-function experiments show this gene, foxa2, is required to generate dopamine neurons during fetal
developmentandfromembryonicstemcells.Micecarryingonlyonecopyofthefoxa2geneshowabnormalitiesinmotor
behavior in old age and an associated progressive loss of dopamine neurons. Manipulating forkhead function may
regulate both the birth of dopamine neurons and their spontaneous death, two major goals of regenerative medicine.
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Introduction
Midbrain dopamine neurons play important roles in motor
control, reward, addiction, attention, and cognition [1,2]. A
progressive loss of dopamine neurons is a deﬁning feature of
Parkinson disease. This disease will cause increased hardship
in many countries, as 30% of the population will be over the
age of 65 y around 2025 [3]. Dopamine neurons are normally
generated in limited numbers, for a restricted time, in a small
region of the embryonic midbrain [4]. To improve access to
these neurons, techniques have been developed to derive
them from precursors dissected from the fetal midbrain and
from pluripotent embryonic stem (ES) cell lines [5–11].
Despite this effort, our knowledge of the mechanisms
controlling the birth and death of these cells is still limited.
Foxa2 is a forkhead transcription factor known to play a
critical role in the early development of the endoderm and
midline structures, including the notochord and ﬂoor plate
[12–16]. FOXO transcription factors are closely related to the
foxa genes and have a central role in cell survival, cancer, and
the longevity of organisms [17–19]. Here, we show that
midbrain dopamine neurons are derived from the ﬂoor plate
and that foxa2 plays a central role in specifying dopamine
neurons. Late in life, foxa2 heterozygous mice spontaneously
develop signiﬁcant motor problems and an associated late-
onset degeneration of dopamine neurons. The initial deﬁcit
is asymmetric and preferentially affects dopamine neurons of
the substantia nigra (SN) while leaving the ventral tegmental
area (VTA) intact, a pattern of sensitivity also seen in
Parkinson patients [20].
Results
Dopamine neurons can be identiﬁed by expression of
tyrosine hydroxylase (TH), the rate-limiting enzyme in
dopamine synthesis. In the nervous system, foxa2 expression
is restricted to the ﬂoor plate, a specialized ventral region
that regulates the differentiation of nearby neurons by
secreting the morphogenic signal sonic hedgehog (SHH)
[14,15]. The newly generated dopamine neurons form a band
at the most ventral edge of the midbrain and express FOXA2
in their nuclei (Figure 1A and 1B). A panel of antibodies
against transcription factors was used to deﬁne the domains
of neuronal precursors in the ventral midbrain (Figure S1).
The expression of the transcription factors LMX1b, NKX2.2,
and PHOX2a between embryonic day (E)9.5 and 11.5 deﬁnes
three adjacent ventral domains of neural progenitors before
the ﬁrst dopamine neurons are formed (Figure 1C). The
transcription factor LMX1b is expressed in the most ventral
domain, the medial ﬂoor plate, continuously from E9.5
through E11.5 (Figure S1C–S1E).
SHH is coexpressed with LMX1b in the ﬂoor plate (Figure
1D). From previous studies, it is unclear whether SHH-
expressing cells are the direct precursors to dopamine
neurons or if they are derived from a more lateral precursor
that is induced by signals from the ﬂoor plate [21–23].
Genetic tracing using Cre-recombinase expressed from the
shh regulatory sequences (shh-creR26R mice) allows the
derivatives of these most medial cells to be identiﬁed [24].
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PLoS BIOLOGYWhen shh-cre mice were crossed with the R26R reporter
strain, the expression of ß-galactosidase is surprisingly found
outside the midline (Figure 1E and inset). At E15.5, when the
majority of dopamine neurons have become postmitotic, they
express TH and also express ß-galactosidase, deﬁnitively
demonstrating that midbrain dopamine neurons are derived
from the medial ﬂoor plate (Figure 1F–1H).
For the efﬁcient ex vivo generation of dopamine neurons,
it is important to understand the mechanisms that induce
dopamine neuron identity. SHH gives increased numbers of
dopamine neurons in midbrain primary explants and in
neuronal cultures derived from ES cells [8,22,23]. This effect
is thought to reﬂect the morphogenic induction of the
dopaminergic fate. Access to reagents that deﬁne distinct
precursor types allows the morphogenic effects of SHH in
vitro to be reexamined. When dissociated cells from the
developing ventral midbrain (E8.5) were exposed to increas-
ing concentrations of SHH, the proportion of LMX1b
þ cells
did not change, but the proportion of the NKX2.2
þ and
NKX6.1
þ cells increased while the more dorsal PAX7
expression decreased (Figures 2A and S2). This result shows
that, under these conditions, SHH does not induce the
precursors of dopamine neurons, whereas the proportion of
more lateral precursors is altered in the graded way expected
of a morphogenic signal. However, SHH is also a mitogen for
neural precursors and this mitogenic effect may account for
the increased number of dopamine progenitors (Figure 2B).
These results suggest that growth control systems for
dopamine neuron precursors are distinct from most other
ventral midbrain neuron types.
A consequence of these results is that production of
dopamine neurons in the laboratory will be limited by the
number of ﬂoor plate cells. As foxa2 is known to control the
generation of the ﬂoor plate, we asked whether this gene
controls the number of TH-positive cells in vitro. Because
foxa2-null embryos do not survive past E10.5, E8.5 midbrain
explants from foxa2 homozygous mutant (n ¼ 8) and control
embryos (n ¼ 12) were placed in culture. Neural progenitors
migrate out from the explant and differentiate into Tuj1-
positive neurons. In all of the wild-type explants, TH
þ
neurons were abundant (Figure 2C). In contrast, the mutant
explants generated no TH
þ neurons (Figure 2D). Using
transcription factor expression, the neuron types in the
ventral midbrain were distinguished (Figure S3). The islet1-
positive oculomotor neurons were also absent, but more-
lateral neurons expressing GATA3 and LIM1/2 were gener-
ated in cultures from foxa2
 /  embryos (Figure 2E). These data
show that the foxa2 gene is speciﬁcally required for the
generation of dopamine and motor neurons, the two neuron
types derived from the ﬂoor plate.
To ask whether expression of foxa2 would cause an increase
in the number of dopamine neurons generated in vitro, a
foxa2 expression plasmid was transfected into E10.5 midbrain
cells. A 4-fold increase in the proportion of TH
þ cells was
observed (Figure 2F). A mouse embryonic stem (mES) cell line
engineered to inducibly express a foxa2 transgene generated
7-fold more TH
þ cells (Figure 2G). The SHH antagonist,
cyclopamine, inhibited the production of TH
þ neurons in
vitro. This effect was reversed upon induction of foxa2 even in
the presence of cyclopamine (Figure 2H). These results are
consistent with an early role for shh in dopamine neuron
speciﬁcation demonstrated in mice carrying a conditional
mutation in the SHH receptor smoothened [25]. Genetic
analysis in zebraﬁsh also demonstrates a role for foxa2 in
the speciﬁcation or patterning of ventral neurons in the
midbrain and hindbrain [26]. Our data suggest that foxa2
speciﬁes dopamine neurons in mammals.
Dopamine neurons in the adult brain continue to express
foxa2 (Figure 3A). A foxa2 null allele was crossed into the
C57BL/6 strain because this background is widely used in
physiological and behavioral studies. Mice entirely lacking
foxa2 die in early development. In all the data reported here,
the effect of a single copy of the foxa2 gene, haploinsufﬁ-
ciency, was assessed in a C57BL/6 background. Haploinsufﬁ-
cient mice spontaneously developed major motor
abnormalities. These behaviors were ﬁrst observed at 18 mo
of age when mice present with an asymmetric posture
associated with a muscular rigidity that progresses from the
tail, through the hind limbs, to the trunk. foxa2
þ/  animals
showed a slower speed of movement but reduced horizontal
movement and a complete loss of vertical movement (Figure
3B–3D, foxa2
þ/þ n ¼ 6, foxa2
þ/  n ¼ 4; Video S1). The mice
demonstrate a unilateral constriction/torsion of the trunk so
the spine becomes curved towards either the left or right side.
In a group of affected animals, the spinal curvature was 158
measured by analysis of footprints (Figure 3E). Occasional
episodes of high-frequency tremoring have been observed.
Rigidity and loss of mobility in the hindlimbs become so
severe that the limb is abnormally extended or splayed
(Figure 3G).
These defects could be caused by deﬁcits in non-dopami-
nergic systems. A widely used and quantitative behavioral
assay of dopaminergic function in rodents is amphetamine-
induced rotation [27]. Rats or mice lesioned acutely and
unilaterally with 6-OHDA circumambulate ipsilaterally in
response to amphetamine, and the extent of rotational
movement is directly correlated with the severity of the
lesion. We assayed amphetamine-induced rotational behavior
in old foxa2
þ/  and wild-type C57BL/6 mice. A signiﬁcant
increase in rotational movement was observed in foxa2
mutants (Figure 3F). Rotations occurred in the clockwise or
counterclockwise direction, depending on the individual
mouse, and were ipsilateral to the ‘‘kinked’’ side of the
mouse. In the ventral midbrain of 1-y-old heterozygous
PLoS Biology | www.plosbiology.org December 2007 | Volume 5 | Issue 12 | e325 2876
The Birth and Death of Dopamine Neurons
Author Summary
The restoration of dopamine neurons is a major focus of stem cell
biology and regenerative medicine. The gradual loss of these
neurons is a hallmark of Parkinson disease. Dopamine neurons in the
midbrain convey important sensory and motor functions to the
forebrain. We show that the transcription factor FOXA2 plays a
central role in the birth and death of dopamine neurons in the
midbrain. By defining their precursors in the ventral midbrain, we
show that dopamine neurons are derived from organizer cells in the
floor plate (the ventral cells of the neural tube, the embryonic
foundation of the central nervous system). We also show that
FOXA2 specifies the floor plate and induces the birth of dopamine
neurons. Mice with only a single copy of the foxa2 gene acquire
motor deficits and a late-onset degeneration of dopamine neurons.
This spontaneous cell death preferentially affects neurons associated
with Parkinson disease. This work provides new strategies to
generate neurons in the laboratory and to block their death in old
age.animals, there is a partial loss of FOXA2 protein, suggesting
that a reduced level of the FOXA2 protein leads to a
behavioral deﬁcit that spontaneously appears in old age
(Figure 3H).
The amphetamine-induced rotational behavior suggests an
asymmetric loss of dopamine neurons. Immunohistochemis-
try for TH-positive cells was performed to shed light on
potential cellular causes of the motor problems. Affected
Figure 1. Floor Plate Origin of Dopamine Neurons
(A and B) Initial differentiation of dopamine neurons is in the medial domain of the foxa2-expressing floor plate. Low (A) and high (B) magnification
images of E12.5 midbrain stained for FOXA2 (red) and tyrosine hydroxylase (green). Note that the newly born dopamine neurons continue to express
foxa2.
(C) Schematic of the ventral progenitor domains of the embryonic mesencephalon. Dopamine precursors (DA) occupy the ventral-most position in the
mesencephalon, the medial floor plate (MFP), whereas the lateral floor plate (LFP) is comprised of oculomotor neuron precursors (MN). V3 precursors
are on either side of the floor plate, in the ventral basal plate (BP). V3 precursors are not the most-ventral neuronal progenitor in the midbrain, as they
are in the spinal cord, because mesencephalic floor plate cells undergo neurogenesis. The expression of LMX1b, PHOX2a, and NKX2.2 expression are
shown in Figures S2 and S3. NKX6.1 expression in the midbrain is shown in Figure S3.
(D) SHH (red) and LMX1b (green) are coexpressed in the floor plate of the embryonic midbrain.
(E) ß-galactosidase staining in the E15.5 midbrain of a shh-cregfp:: ROSA26 mouse fetus. In this mouse, ß-galactosidase is expressed in the shh-
expressing cells of the floor plate and their derivatives. Inset contains a low-power image of a coronal section of the midbrain showing that the blue ß-
galactosidase signals is restricted to the most ventral region.
(F–H) Immunohistochemical localization in (F) and (G) shows that both TH (green) and ß-galactosidase (red) are expressed in the same cells,
demonstrating a floor plate origin for dopamine neurons. (G) Inset: enlargement of boxed cells showing colocalization of TH and ß-galactosidase at the
single-cell level. (H) Another enlarged field contains numerous neurons coexpressing TH and ß-galactosidase.
doi:10.1371/journal.pbio.0050325.g001
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The Birth and Death of Dopamine NeuronsFigure 2. The In Vitro Role of foxa2 and SHH in Cell Fate Specification in the Ventral Mesencephalon
(A) Effects of Shh on E8.5 mesencephalic precursors in vitro. In the absence of exogenous SHH, many LMX1b
þ precursors (36.59 6 6.10%) were
observed. NKX2.2
þ (19.83 6 4.39%), NKX6.1
þ (30.47 6 6.72%), and PAX7
þ precursors (16.33 6 5.02%) were present. In the presence of 500 ng/ml of
SHH protein, the proportion of NKX2.2
þ (41.84 6 5.84%) and NKX6.1
þ (56.62 6 7.04%) cells increased, whereas, the proportion of PAX7
þ cells
diminished (6.89 6 2.54%). Despite these effects on other cell types, the proportion of LMX1b
þ dopamine precursors was stable (32.48 6 5.56%).
Higher concentrations of SHH would be expected to further ventralize the midbrain precursors at the expense of more dorsal fates. In the presence of 1
lg/ml of SHH protein, there was a further increase in NKX2.2
þ and NKX6.1
þ cells (nkx2.2
þ, 52.75 6 6.34%; nkx6.1
þ, 69.12 6 8.73%) and a greater
reduction of PAX7
þ cells (2.24 6 0.81%). At this high concentration of SHH, the percentage of dopamine precursors again remained unchanged (33.04
6 6.61%).
(B) SHH has a proliferative effect on mesencephalic precursors in cell culture. BrdU was added to day 3 cultures of mesencephalic precursors, grown in
different concentrations of SHH protein. BrdU was added for 1 h before fixation and staining. The percentage of cells incorporating BrdU increased with
the concentration of SHH in the culture.
(C) Wild-type mesencephalic explants differentiate to generate a large number of neurons (Tuj1, green) and a significant proportion of these neurons
express tyrosine hydroxylase (TH, red).
(D) Mesencephalic explants from foxa2
 /  embryos also generate many neurons, but TH expression is absent.
(E) foxa2
 /  explants similarly do not yield islet-1–expressing motor neurons although the differentiation of GATA3- and LIM1/2-positive neurons born
outside of the floor plate is unaffected. The developmental expression pattern of these proteins can be seen in Figure S3.
(F) Overexpression of foxa2 in cultured E10.5 mesencephalic explants results in an increase in TH-expressing dopamine neurons.
(G) Doxycycline induction of foxa2 in differentiating F4 mouse embryonic stem cells significantly increases the number of resulting dopamine neurons.
(H) Inhibition of SHH signaling by cyclopamine suppresses dopaminergic differentiation of ES cells. The induction of foxa2 by doxycycline overcomes
cyclopamine suppression of dopamine neuron differentiation.
doi:10.1371/journal.pbio.0050325.g002
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The Birth and Death of Dopamine Neuronsmice demonstrated an asymmetric loss of TH expression in
midbrain dopamine neurons in the SN sparing the VTA
(Figure 4A and 4B). No loss of dopamine neurons was seen in
old foxa2 mutants without behavioral abnormalities (Figure
4C and 4D). In the SN of affected foxa2
þ/  animals, there are
few neurons recognized by Nissl staining (Figure 4E). Serial
sections through the midbrain dopaminergic system of a
single animal show an almost total loss of TH
þ neurons in the
SN on one side of the brain and much less damage to the
contralateral SN (Figure S4). In foxa2
þ/  animals (n ¼ 3)
showing abnormal motor behaviors, compared to foxa2
þ/þage-
matched controls, there is a speciﬁc loss of SN neurons
Figure 3. foxa2 and the Adult Midbrain
(A) Coronal section through adult mouse midbrain stained showing that foxa2 is expressed in dopamine neurons of the SN and VTA of the adult mouse
midbrain. ([A], inset) Enlargement of cells in (A) showing colocalization of TH and FOXA2 at the single cell level.
(B–E) Analyses of motor behavior in mutant and wild-type mice. (B) Horizontal movement of mutant (red) and wild-type (blue) mice in the activity
monitor. (C) Vertical movement (rearing) of mutant (red) and wild-type (blue) mice in the activity monitor. Note that mutant mice do not rear at all. (D)
Speed of mutant (red) mice is compromised relative to wild-type (blue) mice. (E) Footprint analysis was used to quantitate the angle of spinal curvature
in mutant mice and age-matched wild-type mice.
(F) Amphetamine significantly induces rotational movement in foxa2
þ/  as compared to wild-type controls.
(G) Image of 18-mo-old foxa2
þ/  mouse with a rigid right rear limb.
(H) Western analysis of matched 1-mm sections of ventral midbrain shows a reduction of FOXA2 protein in foxa2
þ/  mice as compared to wild-type
controls. As a loading control for total protein, beta-actin staining is shown below.
doi:10.1371/journal.pbio.0050325.g003
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The Birth and Death of Dopamine Neurons(Figure 4G). This loss of dopamine neurons occurs in one
third of animals over 18 mo old, and the asymmetric cellular
loss explains the amphetamine induced rotation.
Within the SN, there are different types of dopamine
neurons. The most ventral neurons speciﬁcally express
retinaldehyde dehydrogenase-1 (RALDH1; [28]). In foxa2
mutant mice, there is a loss of RALDH1-positive neurons
even when substantial numbers of dopamine neurons are still
present in the SN. In the animal shown in Figure 4F, the SN
on one side of the brain has a severe loss of dopamine
neurons. In the contralateral SN, TH-positive cells are
present, but there is a selective loss of RALDH1-positive cells
Figure 4. Dopamine Neuron Loss in foxa2
þ/  Mice
(A and B) Dopamine neurons in a 24-mo-old wild-type mouse (A) and a foxa2
þ/  littermate (B). The mouse in (B) possessed a kinked posture and the
other late-onset motor phenotypes. A significant loss of nigral dopamine neurons is easily observed on one side of the brain marked by a blue star in
the foxa2
þ/  mouse.
(C and D) TH staining of the the ventral midbrain in older foxa2
þ/  animals without late onset behavioral abnormalities. Note that the dopaminergic
system resembles the wild-type condition seen in (A).
(E) Nissl staining of wild-type and foxa2
þ/  mutant mice. Representative glia and neurons are highlighted with white and black arrows, respectively.
Note the significant loss of normal neuronal morphologies in the mutant animal. Occasionally, a dysmorphic cell, highlighted here with a purple arrow,
can be seen in the mutant, but not the wild-type brain.
(F) Ventral tier dopamine neurons, stained for RALDH1 (red), are selectively lost in foxa2
þ/  animals. In this animal, nigral dopamine neurons are almost
completely lost on the left side (marked by the blue star), whereas the right side (marked by the red sun) is much less affected (note that these are
coronal sections, presented as if the animal were facing the viewer, so that the left side of the animal is on the viewer’s right side.
(G) Quantitation of dopamine neurons in the SN and VTA of wild-type (n¼3) and foxa2
þ/ (n¼3) mice. The number of dopamine neurons in the mutant
SN (2,765.0 6 750.5) is substantially smaller than in the control SN (7,344.3 6 197.9). In contrast, the number of the dopamine neurons in the VTA is
roughly the same in wild-type (9,922.0 6 375.7) and mutant mice (10,064.7 6 355.4).
(H) The percentage of RALDH1-expressing neurons in the SN is reduced in foxa2
þ/  mutants as compared to wild-type controls.
doi:10.1371/journal.pbio.0050325.g004
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The Birth and Death of Dopamine Neurons(Figure 4F and 4H). Many of the affected animals show an
asymmetric loss of dopamine neurons, and the most affected
side could be either the right or left (marked by a star in
Figures 4B and 4F). These data suggest the degenerative
process is progressive, the RALDH1-positive neurons are the
most vulnerable cells, and the SN on one side of the brain is
affected ﬁrst and then the disease progresses to the
contralateral midbrain.
Lewy bodies, cellular inclusions immunoreactive for alpha-
synuclein, ubiquitin, and other proteins, are often found in
the basal ganglia and cortex of the human parkinsonian brain
[29]. Pathological staining for alpha-synuclein was not
observed in foxa2 mutant mice, but a small number of TH-
expressing dopamine neurons that were highly immunor-
eactive for ubiquitin were seen in the SN of mutant but not in
wild-type C57BL/6 mice. Gliosis is an activation of astrocytes
that often occurs in neurodegenerative disease [30]. Accom-
panying the loss of dopamine neurons in foxa2 mutants, there
is an increase in the number of activated glia measured by
expression of the glial ﬁbrillary acidic protein (GFAP) in the
substantia nigra pars compacta, in the substantia nigra pars
reticulata, and other regions of the ventral midbrain (Figure
S5A–S5D). In contrast to neuron loss, this activation occurs in
a symmetric manner.
Discussion
Rigidity, tremor, reduced and slow movement with
asymmetric behavioral features, and dopamine neuron loss
are characteristically found in Parkinson patients [31]. The
age-dependent motor defects and the late loss of dopamine
neurons seen in foxa2
þ/  mice are similar to symptoms of
Parkinson disease. In mammalian cells, survival is controlled
by phosphorylation of FOXO proteins that respond to
oxidative stress by regulating apoptosis [32.33]. Overexpres-
sion of pha-4, the nematode foxa homolog, in Caenorhabditis
elegans induces the superoxide dismutase, sod-1, and increases
longevity [34]. These data suggest that FOXA2 regulates the
response of dopamine neurons to oxidative stress, but it is
clear that a cell autonomous function in dopamine neurons
should be explicitly assessed.
In this report, we have shown that mice heterozygous for a
mutation in foxa2 develop a late-onset condition associated
with a signiﬁcant loss of midbrain dopamine neurons. It will
be important in the future to determine how functional
interactions with other brain regions are altered as the
dopamine neurons degenerate. Here, we show the neurons of
the SN are more sensitive than the neurons of the VTA to the
pathology in foxa2
þ/  mice. Asymmetric motor deﬁcits and
preferential loss of nigral neurons are characteristic in
disorders of the nigrostriatal system [20]. The asymmetric
degeneration of nigral dopamine neurons shows that foxa2
þ/ 
mice model features of human degenerative disease not
previously seen in animal models.
Oxidative stress is considered to be a primary cause of
Parkinson disease [35,36]. Recent studies have identiﬁed
mutations in a number of genes (PARK genes) associated
with Parkinson disease. These genes include a-synuclein [37],
parkin [38], DJ-1 [39], PINK1 [40], and most recently, LRRK2
[41,42]. Mice have been generated with mutations in many of
the PARK genes but, surprisingly, spontaneous degeneration
of dopamine neurons and motor function deﬁcits have not
been observed in these animals. The forkhead transcription
factors are targets of the PI3K/Akt signaling pathway that is
an important regulator of cell growth and survival [43].
Growth factors proposed as treatments for Parkinson disease
also act through this pathway [44]. Recently, genes associated
with human parkinsonism have been shown to be regulators
of the PI3K/Akt pathway [45.46]. The clear cell loss reported
here suggests that FOXA2 is the transcriptional effector of
dopamine neuron survival. It will be interesting to analyze
potential interactions between FOXA2, mutant PARK genes,
and neurotrophic factors.
This spontaneous model is important because it will allow
us to understand the dynamics of dopamine neuron
degeneration. In the SN of Parkinson patients, the
RALDH1-expressing ventral dopamine neurons are partic-
ularly vulnerable to the etiology of Parkinson disease [47]. An
initial asymmetric motor deﬁcit, an asymmetric dopamine
loss measured by positron emission tomography (PET)
scanning, and dopamine neuron pathology are characteristic
features of Parkinson disease [31,48]. Most studies on whole
animals that address Parkinson disease use speciﬁc toxins to
kill dopamine neurons [49]. Toxins are valuable, and they can
speciﬁcally target the ventral tier neurons at risk in Parkinson
disease, but they inadequately address the progressive nature
of the disease and the increased sensitivity with age [50].
foxa2
þ/  animals give us access to the normal mechanisms that
initiate and sustain loss of neurons in the SN. There would be
great clinical beneﬁt if the progression of disease could be
slowed when patients are ﬁrst diagnosed.
We present data that address the related questions: how to
make dopamine neurons efﬁciently in the laboratory and how
to support their survival in the brain. We present a precise
map of the distinct origin of dopamine neurons that is
fundamental to solving a major current problem in cell
therapies for Parkinson disease, the identity of dopamine
neurons in the graft. However, our data have a signiﬁcance
that goes beyond the technology of cell therapy. Stem cell
biology is often criticized for the slow transition to explicit
clinical beneﬁt. The work presented here illustrates how a
developmental approach that is implicit in stem cell biology
leads to a focus on the mechanisms that control the origin
and survival of the cell of interest. In the case of dopamine
neurons, our data suggest a central role for the PI3K/Akt/Fox
survival pathway in deﬁning the origin of dopamine neurons
and developing an effective response to Parkinson disease.
Materials and Methods
Immunohistochemistry and histology. Timed pregnant CD-1 mice
(Charles River Laboratories) were obtained and embryos were
manually dissected and ﬁxed in 4% paraformaldehyde (PFA) in
PBS, transferred to 20% sucrose overnight, and embedded in O.C.T
compound (Tissue Tek, Sakra). 12-lm sections were cut on a Microm
MH 500 OM cryostat and processed for immunohistochemistry.
Sections stained with the anti-SHH antibody were treated with 50
mM NH4Cl for 20 min at room temperature and washed twice with
PBS prior to incubation with the primary antibody.
Adult mice were anesthetized with pentobarbital sodium (Nem-
butal) and perfused with 20 ml of PBS followed by 40 ml of 4% PFA.
Brains were dissected out, transferred to 20% sucrose overnight, and
40-lm sections were cut on a cryostat and maintained as ﬂoating
sections in PBS. Immunostaining was visualized on a confocal
microscope. All animal work was carried out in accordance with
National Institute of Neurological Disorders and Stroke (NINDS)
Animal Studies Protocols 1204–05, 1205–05, and 1247–05, as
approved by the NINDS Animal Care and Use Committee. Cell
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directly at the microscope. In cases in which cell density made it
difﬁcult to easily discern individual cells, cell bodies stained for TH,
RALDH1, and GFAP were matched to their DAPI-labeled nuclei. To
estimate the absolute number of midbrain dopamine neurons, we
multiplied the total number of cells by six (sampling frequency) and
made the Abercrombie correction. We measured the nuclei of 50
midbrain dopamine neurons, both in the SN and VTA, and
determined the mean nuclear diameter to be 8.69 lm, which we
used for the Abercrombie correction.
For Nissl staining, 40-lm brain sections were washed in distilled
water and mounted on slides. Sections were treated with cresyl violet
for 5 min and then washed again in distilled water. Slides were then
run through an ethanol series (50%, 70%, 90%, 95%, and 100%) and
ﬁnally dipped in xylene for 2 min, before mounting in Permount.
Antibodies. For immunohistochemistry of mouse embryo sections
and ﬁxed cells in vitro, the following antibodies were used: b-
galactosidase (1:500, rabbit monoclonal; Biogenesis); BrdU (1:200, rat
monoclonal; Axyll); FOXA2, Islet1, LIM1/2, NKX2.2, PAX7, and SHH
(1:10, mouse monoclonal; Developmental Studies Hybridoma Bank,
University of Iowa); FOXA2 (1:4,000, rabbit polyclonal; gift of Ariel
Ruiz I Altaba); FOXA2 (1:50, goat polyclonal; Santa Cruz Biotechnol-
ogy); GATA3 (1:200, mouse monoclonal; Santa Cruz Biotechnology);
GFAP (1:500, rabbit polyclonal; DAKO); LMX1b (1:4,000, guinea pig
polyclonal; gift of T. Jessell); LMX1b (1:500, rabbit polyclonal; gift of
T. Muller); nestin (1:500, rabbit polyclonal; McKay lab); NKX2.2
(1:400, guinea pig polyclonal; gift of B. Sosa Pineda); NKX6.1 (1:1,000,
rabbit polyclonal; gift of M. German); PTX3 (1:400, rabbit polyclonal;
Upstate); RALDH1 (1:100, rabbit polyclonal; gift of Greg Duester);
Phox2a (1:800, rabbit polyclonal; gift of J.-F. Brunet); SOX1 and SOX2
(1:500, rabbit polyclonal. gift of R. Lovell-Badge); and tyrosine
hydroxylase (1:500, rabbit and sheep polyclonals; Pel-freez).
Cell culture. E8.5 embryos (9–13 somites) were obtained from
timed pregnant CD-1 mice (Charles River Laboratories). Embryos
were incubated in N2 medium containing 1% amylase (Sigma) for 1 h
at 37 8C, to facilitate manual dissection. After removal of ectoderm
and head mesenchyme, embryonic midbrains were moved to amylase-
free N2 medium. Pooled tissue was washed 33 in PBS and then
digested in N2 medium containing 0.005% Trypsin-EDTA (Gibco) for
5 min at room temperature. Dissociated mesencephalic cells were
added to N2 medium containing Trypsin Inhibitor (Sigma), 100 ng/ml
FGF2, 100 ng/ml (FGF8), and 500 ng/ml Shh (R&D Systems). Three
embryo equivalents of mesencephalic cells were plated per well in a
24-well plate (Costar), coated with poly-L-ornithine (Sigma) and
ﬁbronectin (R&D Systems). Upon cell attachment, the medium was
changed to N2 medium (without trypsin inhibitor) containing 100 ng/
ml FGF8 and shh. Cells were ﬁxed with 4% PFA after 4 d of
expansion. To assay cell proliferation, cells were treated with 10 lM
BrdU (Roche) for 1 h prior to ﬁxation. Four independent experi-
ments were performed in which each condition was analyzed in
duplicate wells.
CNS explants were dissected from E8.5 foxa2
 /  embryos and wild-
type embryos. Explants were plated directly in N2 medium contain-
ing 100 ng/ml FGF8 and 500 ng/ml shh, as described above. After 4 d
in culture with mitogens, the explants were grown for four additional
days in the absence of exogenous growth factors to promote
differentiation. After 4 d of differentiation, the explants were ﬁxed
with 4% PFA.
For overexpression of foxa2, E10.5 embryonic midbrain cells were
harvested and plated in a manner identical to the E8.5 experiments,
above, with the exception that two embryo equivalents of mesen-
cephalic cells were plated per well of a 24-well plate (Costar). Cells
were transfected, using the lipofectamine reagent (Invitrogen), with a
CMV-foxa2 vector (generous gift of R.J. Matusik) and with a GFP
expression vector (gift of T. Misteli, National Cancer Institute).
The mouse embryonic stem cell line, F4, which expresses foxa2
inducibly, under the control of doxycycline, will be described in
greater detail elsewhere (A. Kuzmichev and R. D. G. McKay,
unpublished data). Brieﬂy, these cells were generated by homologous
recombination into the HPRT locus using a vector modiﬁed from a
previously described vector [51] in which the oct4 transgene was
replaced by foxa2. We differentiated the mES cells to neurons using a
method modiﬁed from a previously described protocol [52].
Approximately 50,000 F4 cells were plated per well of a ﬁbronec-
tin-coated, 24-well plate into N2 medium. The cells were differ-
entiated for 28 d in N2, in the absence of exogenous growth factors.
foxa2 was induced using doxycycline from days 6–23 of culture (no
induction for the ﬁrst and last 5 d of the differentiation).
Behavior. Spontaneous motor activity was analyzed using the
Versamax Animal Activity Monitoring System (AccuScan Instru-
ments). Animals were placed into the 16.5’’ by 16.5’’ chamber for 60
min where vertical and horizontal movements detected by infrared
beams were analyzed by VersaMax software. When wild-type and
mutant mice were compared, there was no simple difference in the
time spent in the center of the chamber. For amphetamine-induced
rotation, mice were injected with 2.5 mg/kg of amphetamine
intraperitoneally, and clockwise and counterclockwise rotations were
measured using the Rota-count 8 system (Columbus Instruments) for
60 min.
Supporting Information
Figure S1. Expression of Transcription Factors in Ventral Midbrain
Progenitors
(A–H) Transverse sections through mouse mesencephalon at E9.5 (C)
and (F), E10.5 (A), (B), (D), and (G), and E11.5 (E) and (H), stained with
anti-LMX1b (green in [A], [C], and [E]; red in [D]), anti-PHOX2a (red
in [A]; green in [B] and [F–H]), anti-NKX2.2 (red in [B]), and anti-
FOXA2 (red in [C], [E], and [F–H]; green in [D]) antibodies. Double-
staining is indicated by yellow.
(A) LMX1b expression (dopamine precursors) occurs in a single
domain at the ventral midline. PHOX2a
þ cells (oculomotor neuron
precursors) are observed in an immediately adjacent, nonoverlapping
domain.
(B) NKX2.2-expressing cells (V3 neural precursors) occupy the
domain immediately dorsal to the motor neuron precursor domain.
Some expression of NKX2.2 can be observed in PHOX2a-expressing
domain.
(C–E) Dopamine precursors express the ﬂoor plate marker, FOXA2,
and are found in the medial part of this domain. LMX1b
þ cells are
found in the medial FOXA2
þ domain.
(F–H) PHOX2a
þ cells are found in the lateral parts of the FOXA2
þ
domain. Numerous PHOX2a
þ precursors coexpress FOXA2 at E9.5
(F). As these cells migrate to the pial surface, they down-regulate
FOXA2 (G) and (H).
Found at doi:10.1371/journal.pbio.0050325.sg001 (1.1 MB PDF).
Figure S2. Expression of nkx Genes in Relation to the Mesencephalic
Floor Plate
Transverse sections through mouse mesencephalon at E9.5 (B), E10.5
(A) and (C), and E11.5 (D), stained with anti-FOXA2 (green in [A]; red
in [B–D]), anti-NKX2.2 (red in [A]), anti-NKX6.1 (red in [B–D])
antibodies. The NKX2.2-expressing cells in (A) ﬂank the FOXA2
þ
ﬂoor plate in the midbrain, just as they do in the developing spinal
cord.
Found at doi:10.1371/journal.pbio.0050325.sg002 (695 KB PDF).
Figure S3. Expression of Transcription Factors in Neurons of the
Ventrolateral Fetal Midbrain
(A) GATA3 expression is observed in a subset of neurons differ-
entiating in the NKX6.1 domain E10.5.
(B and C) At E11.5, GATA3
þ neurons are located immediately
adjacent to the NKX6.1
þ motoneurons (B). Like GATA3, LIM1/2 is
expressed in neurons immediately adjacent to the NKX6.1-expressing
motor neurons (C). In (B) and (C), NKX6.1 expression is lost as
progenitors differentiate to GATA3- and LIM1/2-positive neurons.
(D) At E12.5, motor neurons are identiﬁed by PHOX2a expression,
and more lateral neurons by LIM1/2 expression. LIM1/2 expression at
E12.5 expands dramatically, compared to E11.5 (C).
Found at doi:10.1371/journal.pbio.0050325.sg003 (461 KB PDF).
Figure S4. Gliosis in foxa2
þ/  Mice
(A) Widespread gliosis is seen in the ventral midbrain of foxa2
þ/  mice
(TH, green; GFAP, red).
(B and C) Increased density of glia is easily seen in the red nucleus of
wild-type (B) and foxa2
þ/  mice (C).
(D) Quantitation of glia in wild-type and foxa2
þ/  dopaminergic
system throughout the VTA, the SN pars compacta and reticulata,
and red nucleus.
Found at doi:10.1371/journal.pbio.0050325.sg004 (2.3 MB PDF).
Figure S5. Severe Asymmetric Loss of Nigral Dopamine Neurons in
One Mouse
Coronal sections through the midbrain of a wild-type (A), (C), (E), (G),
and (I) and a foxa2
þ/  (B), (D), (F), (H), and (J) mouse at the indicated
level. There is an almost complete loss of nigral dopamine neurons on
PLoS Biology | www.plosbiology.org December 2007 | Volume 5 | Issue 12 | e325 2882
The Birth and Death of Dopamine Neuronsthe left side, whereas the right side is relatively intact, quantitated in
(K).
Found at doi:10.1371/journal.pbio.0050325.sg005 (684 KB PDF).
Video S1. foxa2 Mutant with Late-Onset Motor Phenotype
This is a 20-mo-old foxa2 heterozygote in a C57BL/6 background that
has developed the late-onset motor problems characterized, here.
Note the asymmetric kinked posture and the labored gait in this
mouse.
Found at doi:10.1371/journal.pbio.0050325.sv001 (1.3 MB MPG).
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